The Chemical Bank Purchases 44 Shares of UnitedHealth Group Incorporated (UNH)

The Chemical Bank Purchases 44 Shares of UnitedHealth Group Incorporated (UNH)

Chemical Bank boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,576 shares of the healthcare conglomerate’s stock after buying an additional 44 shares during the period. Chemical Bank’s holdings in UnitedHealth Group were worth $361,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Coconut Grove Bank increased its position in shares of UnitedHealth Group by 19.5% in the third quarter. Coconut Grove Bank now owns 736 shares of the healthcare conglomerate’s stock worth $103,000 after buying an additional 120 shares in the last quarter. Van Hulzen Asset Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth approximately $104,000. First Personal Financial Services increased its position in shares of UnitedHealth Group by 36.9% in the third quarter. First Personal Financial Services now owns 742 shares of the healthcare conglomerate’s stock worth $104,000 after buying an additional 200 shares in the last quarter. Archford Capital Strategies LLC increased its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares in the last quarter. Finally, NewSquare Capital LLC increased its position in shares of UnitedHealth Group by 4.8% in the third quarter. NewSquare Capital LLC now owns 880 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 40 shares in the last quarter. Institutional investors own 84.80% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) traded down 1.82% on Wednesday, hitting $157.74. The stock had a trading volume of 6,591,624 shares. The company has a market cap of $150.14 billion, a price-to-earnings ratio of 23.30 and a beta of 0.67. The company has a 50 day moving average price of $160.96 and a 200-day moving average price of $145.97. UnitedHealth Group Incorporated has a 52-week low of $108.83 and a 52-week high of $164.00.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 17th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.07 by $0.04. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The firm had revenue of $47.50 billion for the quarter, compared to the consensus estimate of $47.12 billion. During the same period in the previous year, the business earned $1.40 EPS. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post $9.52 earnings per share for the current year.

A number of equities analysts recently commented on the company. Barclays PLC restated a “buy” rating and set a $187.00 target price on shares of UnitedHealth Group in a report on Monday, January 9th. Jefferies Group reaffirmed a “buy” rating and issued a $2.30 price target on shares of UnitedHealth Group in a research note on Tuesday, January 10th. Piper Jaffray Companies assumed coverage on UnitedHealth Group in a research note on Tuesday, January 3rd. They issued an “overweight” rating and a $188.00 price target on the stock. Vetr raised UnitedHealth Group from a “buy” rating to a “strong-buy” rating and set a $189.00 price target on the stock in a research note on Wednesday, December 28th. Finally, Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $180.00 price target on the stock in a research note on Saturday, December 3rd. Twenty-two analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $165.62.

In related news, Director Gail R. Wilensky sold 5,460 shares of the business’s stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $150.55, for a total transaction of $822,003.00. Following the transaction, the director now directly owns 60,052 shares in the company, valued at approximately $9,040,828.60. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP D Ellen Wilson sold 14,365 shares of the business’s stock in a transaction on Friday, October 21st. The stock was sold at an average price of $144.18, for a total value of $2,071,145.70. Following the transaction, the executive vice president now owns 66,635 shares in the company, valued at $9,607,434.30. The disclosure for this sale can be found here. Corporate insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Related posts

Leave a Comment